health

Eczema is becoming a more common disease in the developed parts of
the world, with rates as high as 18 percent in children of some countries.
It is also rising among people who migrate from less developed to more
developed countries. It may be possible in the future to develop medications
that would stimulate filaggrin production in patients with a defective
gene for this skin protein. Another area of research is focused on the
benefits of early protective skin care in children with eczema. Some doctors
think that early treatment of the skin condition may prevent hay
fever, food allergies, and asthma from developing in later childhood, or
at least reduce their severity.